HK1012234A1 - Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection - Google Patents

Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection

Info

Publication number
HK1012234A1
HK1012234A1 HK98113457A HK98113457A HK1012234A1 HK 1012234 A1 HK1012234 A1 HK 1012234A1 HK 98113457 A HK98113457 A HK 98113457A HK 98113457 A HK98113457 A HK 98113457A HK 1012234 A1 HK1012234 A1 HK 1012234A1
Authority
HK
Hong Kong
Prior art keywords
infection
treatment
prophylaxis
herpes virus
purine derivatives
Prior art date
Application number
HK98113457A
Other languages
English (en)
Inventor
Hodge Richard Anthony Vere
Original Assignee
Novartis Int Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Int Pharm Ltd filed Critical Novartis Int Pharm Ltd
Publication of HK1012234A1 publication Critical patent/HK1012234A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK98113457A 1993-11-12 1998-12-15 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection HK1012234A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939323404A GB9323404D0 (en) 1993-11-12 1993-11-12 Pharmaceuticals
PCT/GB1994/002486 WO1995013074A1 (en) 1993-11-12 1994-11-11 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection

Publications (1)

Publication Number Publication Date
HK1012234A1 true HK1012234A1 (en) 1999-07-30

Family

ID=10745092

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98113457A HK1012234A1 (en) 1993-11-12 1998-12-15 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection

Country Status (18)

Country Link
US (1) US6051579A (zh)
EP (1) EP0728002B1 (zh)
JP (1) JP3821840B2 (zh)
KR (1) KR100341736B1 (zh)
CN (1) CN1071572C (zh)
AT (1) ATE210445T1 (zh)
AU (1) AU696833B2 (zh)
CA (1) CA2176392C (zh)
CY (1) CY2337B1 (zh)
DE (1) DE69429447T2 (zh)
DK (1) DK0728002T3 (zh)
ES (1) ES2169117T3 (zh)
GB (1) GB9323404D0 (zh)
HK (1) HK1012234A1 (zh)
PT (1) PT728002E (zh)
SI (1) SI0728002T1 (zh)
WO (1) WO1995013074A1 (zh)
ZA (1) ZA948908B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475253B2 (en) 1996-09-11 2002-11-05 3M Innovative Properties Company Abrasive article and method of making
EP1532151A2 (en) * 2002-08-26 2005-05-25 Teva Pharmaceutical Industries Limited Crystalline solid famciclovir forms i, ii, iii and preparation thereof
JPWO2007029712A1 (ja) * 2005-09-08 2009-03-19 財団法人阪大微生物病研究会 リンパ球系・血球系細胞へ遺伝子導入するためのプロモーターおよびその利用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141927B1 (en) * 1983-08-18 1991-10-30 Beecham Group Plc Antiviral guanine derivatives
EP0182024B1 (en) * 1984-09-20 1991-04-03 Beecham Group Plc Purine derivatives and their pharmaceutical use
DE3671227D1 (de) * 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.
GB8628826D0 (en) * 1986-12-02 1987-01-07 Beecham Group Plc Pharmaceutical products
US4795799A (en) * 1987-09-08 1989-01-03 Phillips Petroleum Company Production of aromatic sulfide/ketone polymers with alkali metal carbonate
AU635642B2 (en) * 1990-05-24 1993-03-25 E.R. Squibb & Sons, Inc. Fluorinated bis(hydroxymethyl) cyclobutyl purines and pyrimidines
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment

Also Published As

Publication number Publication date
CN1136277A (zh) 1996-11-20
JPH09511218A (ja) 1997-11-11
AU8149194A (en) 1995-05-29
CN1071572C (zh) 2001-09-26
EP0728002A1 (en) 1996-08-28
DE69429447T2 (de) 2002-07-25
SI0728002T1 (en) 2002-04-30
ZA948908B (en) 1995-08-17
US6051579A (en) 2000-04-18
ES2169117T3 (es) 2002-07-01
ATE210445T1 (de) 2001-12-15
DK0728002T3 (da) 2002-04-08
CY2337B1 (en) 2004-02-06
AU696833B2 (en) 1998-09-17
WO1995013074A1 (en) 1995-05-18
CA2176392C (en) 2005-11-08
KR100341736B1 (ko) 2002-11-23
EP0728002B1 (en) 2001-12-12
CA2176392A1 (en) 1995-05-18
DE69429447D1 (de) 2002-01-24
GB9323404D0 (en) 1994-01-05
PT728002E (pt) 2002-05-31
JP3821840B2 (ja) 2006-09-13

Similar Documents

Publication Publication Date Title
HUT53522A (en) Process for producing pharmaceutical compositions comprising purine derivatives
AU8447991A (en) Antineoplastic effect potentiator and antineoplastic agent
HK1012234A1 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection
CY2525B1 (en) Use of penciclovir for the treatment of human herpes-virus-8
CY2338B1 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections.
CA2207503A1 (en) Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20111111